-
Mashup Score: 4Novel Tau Blood Biomarker Shows Promise - 6 month(s) ago
Plasma MTBR-tau243 reflects changes in tau pathology and can be used to stage AD tauopathy and to determine if cognitive symptoms are likely due to AD pathology.
Source: www.medscape.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 4Novel Tau Blood Biomarker Shows Promise - 6 month(s) ago
Plasma MTBR-tau243 reflects changes in tau pathology and can be used to stage AD tauopathy and to determine if cognitive symptoms are likely due to AD pathology.
Source: www.medscape.comCategories: General Medicine News, General NewsTweet-
MTBR-tau243 — microtubule-binding region of tau containing the residue 243 — is a specific blood biomarker of tau tangle pathology in patients with #AlzheimersDisease, new research shows. @MedscapeNeuro https://t.co/XtQ9lQAcgl
-
-
Mashup Score: 10Researchers find success with stem cell therapy in mice model of Alzheimer’s disease - 7 month(s) ago
In a Stanford Medicine study, scientists transplanted stem cells into mice and found reduction of brain abnormalities typical of Alzheimer’s disease.
Source: med.stanford.eduCategories: General Medicine News, Latest HeadlinesTweet-
“This cell therapy approach is unique in the field because most researchers are working to find pills or injectables to treat Alzheimer’s disease.” – Marius Wernig, MD, PhD, professor of pathology at Stanford Medicine #AlzheimersDisease #Neuroscience https://t.co/nVZmGZLpgT
-
-
Mashup Score: 2Fast Five Quiz: Alzheimer's Disease Symptoms and Treatments - 8 month(s) ago
Alzheimer’s disease affects approximately 50 million adults worldwide. Do you know the risk factors, symptoms, and potential treatments? Test your knowledge with our quick quiz.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Roughly 50 million adults worldwide are impacted by #Alzheimersdisease. Are you familiar with the risk factors, symptoms, and possible treatments? Evaluate your knowledge with our brief quiz. #MedEd https://t.co/SSodrc2HvQ https://t.co/g6Pqcvsdmy
-
-
Mashup Score: 3Few People May be Eligible for New Alzheimer’s Drug Leqembi - 8 month(s) ago
A new drug can help slow cognitive decline in people with early forms of Alzheimer’s disease, but only a small number of people may be able to take it. Here’s why.
Source: www.healthline.comCategories: General Medicine News, Latest HeadlinesTweet-
A new treatment can help slow cognitive decline in people with early forms of Alzheimer’s disease, but only a small number of people may be eligible for it. Here's why. #ENDALZ #alzheimersdisease https://t.co/vOxgFNUwPm
-
-
Mashup Score: 0There's a New Direct-to-Consumer Test for Alzheimer's Risk - 9 month(s) ago
Quest Diagnostics has released a new direct-to-consumer test that can help people determine their risk of developing Alzhiemer’s disease.
Source: www.healthline.comCategories: General Medicine News, Latest HeadlinesTweet-
There is a new direct-to-consumer blood test to help assess the risk of Alzheimer’s disease. #alzheimersdisease #ENDALZ https://t.co/r8e91F5Jw0
-
-
Mashup Score: 29Blood condition linked to protection against Alzheimer's - 9 month(s) ago
Researchers at Stanford Medicine explore a potentially causative connection between a blood disorder and Alzheimer’s.
Source: scopeblog.stanford.eduCategories: General Medicine News, Latest HeadlinesTweet-
Stanford Medicine researchers have found that a common blood condition associated with several diseases may have a protective effect against Alzheimer's disease. #AlzheimersDisease #Research https://t.co/iqCQokoi10
-
-
Mashup Score: 44Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life - 9 month(s) ago
Proteomics analysis of plasma from middle-aged adults identifies a biologically diverse set of proteins associated with dementia 25 years later.
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet-
A proteome-wide study of more than 10,000 middle-aged adults identifies 15 proteins linked to a higher risk of #dementia and #AlzheimersDisease 25 years later. Learn more in @ScienceTM: https://t.co/6nbIgAIdxE https://t.co/CQVOZ8PKuL
-
-
Mashup Score: 66TRPM7 kinase activity induces amyloid-β degradation to reverse synaptic and cognitive deficits in mouse models of Alzheimer’s disease - 9 month(s) ago
Loss of the kinase activity of TRPM7 may contribute to amyloid pathology in Alzheimer’s disease.
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet-
Loss of the ion channel TRPM7 contributes to the buildup of toxic amyloid proteins in a model of #AlzheimersDisease, suggest new experiments in @SciSignal that flesh out the mechanisms connecting TRPM7 loss with amyloid pathology. #Neuroscience https://t.co/qmKDzDbeMD https://t.co/4RplVt6b7Y
-
-
Mashup Score: 0Diagnosing Alzheimer's Disease in Primary Care - 9 month(s) ago
Dr Larry Culpepper highlights key aspects in the diagnosis and management of this disease in primary care.
Source: www.medscape.comCategories: General Medicine News, Latest HeadlinesTweet-
🧠 Dr Larry Culpepper highlights key aspects in the diagnosis and management of #Alzheimersdisease in primary care. https://t.co/i2UyO5KsQs https://t.co/hLYDhLn2Pk
-
MTBR-tau243 — microtubule-binding region of tau containing the residue 243 — is a specific blood biomarker of tau tangle pathology in patients with #AlzheimersDisease, new research shows. https://t.co/Qv5CgUNuPt